Fig. 3From: Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II studyRelative survival of a) males and b) females with AGel amyloidosis in the FIN-GAR phase II registry and a previous study on survival. RS = relative survival [27]Back to article page